These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6984348)

  • 1. Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia.
    Mertelsmann R; Moore MA; Clarkson B
    Blood Cells; 1982; 8(3):561-83. PubMed ID: 6984348
    [No Abstract]   [Full Text] [Related]  

  • 2. TdT-positive acute leukemia with monocytoid characteristics. Clinical, cytochemical, cytogenetic and immunologic findings. 24 patients.
    Cuttner J; Seremetis S; Najfeld V; Troy KM; Winchester R
    Haematologica; 1987; 72(6 Suppl):113-8. PubMed ID: 3127286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of "terminal deoxynucleotidyl transferase" (TdT) by indirect immunofluorescence, an essential tool in the diagnosis of leukemia].
    Boileau J; Jianian JY
    Union Med Can; 1982 Apr; 111(4):370-3. PubMed ID: 7046185
    [No Abstract]   [Full Text] [Related]  

  • 4. [Terminal deoxynucleotidyl transferase in the diagnosis of malignant lymphomas (author's transl)].
    Tanaka M; Furukawa K; Kaneda T; Mishima H; Fujiwara Y; Nakaide Y; Tanaka M; Hirota Y
    Rinsho Ketsueki; 1979 Nov; 20(11):1429-34. PubMed ID: 537164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of immunoperoxidase method to detection of terminal transferase-positive leukemia cells].
    Sasaki R; Takaku F
    Rinsho Ketsueki; 1982 Apr; 23(4):472-5. PubMed ID: 6752479
    [No Abstract]   [Full Text] [Related]  

  • 6. Terminal transferase in various kinds of leukemia cells and its usefulness as a marker enzyme for vincristine and prednisolone treatment.
    Sakamoto S; Kano Y; Hida K; Sasaki R; Tsuboyama A; Mutoh Y; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):43-52. PubMed ID: 7315145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hematopoietic cancer cells and terminal transferase].
    Tsubota T; Sogawa J; Okazaki M
    Rinsho Byori; 1983 Jun; 31(6):587-94. PubMed ID: 6361330
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of sideroblastic anemia terminating in TdT-positive acute lymphoblastic leukemia].
    Akiyoshi R; Murata I; Kin K; Sakamoto S; Hida K; Kikuchi Y; Kanda M
    Rinsho Ketsueki; 1984 Oct; 25(10):1641-5. PubMed ID: 6596447
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].
    San Miguel JF; Portero JA; Gonzaĺez M; Plaza JP; Caballero MD; De Cecilia A; Fernández JJ; López Borrasca A
    Sangre (Barc); 1983; 28(6):746-52. PubMed ID: 6585006
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
    Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
    Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the role of an immunofluorescent terminal deoxynucleotidyl transferase kit.
    Dunbar DR; Smith C; Thornton JA; Waters HM; Hyde K; Delamore IW
    Scand J Haematol; 1985 Nov; 35(5):474-80. PubMed ID: 3911372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia.
    Grever MR; Coleman MS; Balcerzak SP
    Cancer Res; 1983 Mar; 43(3):1442-5. PubMed ID: 6572097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzyme markers in leukemic disorders].
    Nomura T
    Nihon Rinsho; 1981 Aug; 39(8):2768-72. PubMed ID: 7038201
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphoblastic lymphoma without TdT.
    Saab GA; Carloss H
    N Engl J Med; 1980 Apr; 302(17):969-70. PubMed ID: 6892651
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
    Mertelsmann R; Koziner B; Filippa DA; Grossbard E; Incefy G; Moore MA; Clarkson BD
    Haematol Blood Transfus; 1979; 23():131-8. PubMed ID: 317470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Terminal deoxynucleotidyl transferase - its significance and use in clinical practice].
    Macák J
    Vnitr Lek; 1982 Jul; 28(7):715-7. PubMed ID: 7112996
    [No Abstract]   [Full Text] [Related]  

  • 17. Terminal transferase in normal and leukemic cells.
    Bollum FJ; Chang LM
    Adv Cancer Res; 1986; 47():37-61. PubMed ID: 3535426
    [No Abstract]   [Full Text] [Related]  

  • 18. Philadelphia chromosome and TdT-positive AML.
    Brusamolino E; Isernia P; Bernasconi C; Bertazzoni U
    J Clin Oncol; 1984 Aug; 2(8):970-1. PubMed ID: 6589365
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic importance of lysozymemia and lysozymuria in hematology].
    Iavorkovskiĭ LI; Grant KhIa
    Probl Gematol Pereliv Krovi; 1978 Sep; 23(9):13-7. PubMed ID: 704568
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical laboratory approach to the evaluation of terminal deoxynucleotidyl transferase (TdT) by flow cytometry (FCM).
    Hechinger MK; Hernandez AM; Barr NJ; Parker JW
    J Clin Lab Anal; 1994; 8(4):211-8. PubMed ID: 7931815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.